Toolkit/BcLOVclust

BcLOVclust

Protein Domain·Research·Since 2023

Also known as: cytoplasmic BcLOV4 variant

Taxonomy: Mechanism Branch / Component. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

BcLOVclust is a cytoplasmic BcLOV4-derived protein domain engineered for light-controlled intracellular clustering. It enables optogenetic clustering in mammalian cells and has been applied to control signaling proteins and stress granules.

Usefulness & Problems

Why this is useful

BcLOVclust provides a light-responsive clustering module for manipulating intracellular organization and protein activity in the cytoplasm. The reported value is rapid, reversible clustering over many activation cycles, with substantially faster clustering and de-clustering kinetics than Cry2.

Source:

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.

Source:

While its usage is currently suited for organisms that can be cultured below ∼30 °C

Source:

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.

Problem solved

BcLOVclust addresses the need for a cytoplasmic optogenetic clustering tool with faster on/off dynamics than Cry2. It supports optical control of cellular processes mediated by induced clustering, including signaling proteins and stress granules in mammalian cells.

Source:

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.

Source:

While its usage is currently suited for organisms that can be cultured below ∼30 °C

Source:

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.

Problem links

Need conditional control of signaling activity

Derived

BcLOVclust is a cytoplasmic BcLOV4-derived protein domain engineered for light-controlled intracellular clustering. It supports optogenetic control of signaling proteins and stress granules in mammalian cells and exhibits substantially faster clustering and de-clustering kinetics than Cry2 over many activation cycles.

Need conditional recombination or state switching

Derived

BcLOVclust is a cytoplasmic BcLOV4-derived protein domain engineered for light-controlled intracellular clustering. It supports optogenetic control of signaling proteins and stress granules in mammalian cells and exhibits substantially faster clustering and de-clustering kinetics than Cry2 over many activation cycles.

Need precise spatiotemporal control with light input

Derived

BcLOVclust is a cytoplasmic BcLOV4-derived protein domain engineered for light-controlled intracellular clustering. It supports optogenetic control of signaling proteins and stress granules in mammalian cells and exhibits substantially faster clustering and de-clustering kinetics than Cry2 over many activation cycles.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Component: A low-level protein part used inside a larger architecture that realizes a mechanism.

Techniques

No technique tags yet.

Target processes

recombinationsignaling

Input: Light

Implementation Constraints

cofactor dependency: cofactor requirement unknowncomparator named: Cry2cytoplasmic clustering: Trueencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: spectral hardware requirementoperating role: regulatoroptogenetic: Trueswitch architecture: single chaintemperature sensitive: True

BcLOVclust is described as a cytoplasmic BcLOV4 variant used as a protein domain for light-controlled clustering in mammalian cells. The provided evidence does not specify illumination parameters, cofactors, expression systems, or fusion design requirements.

The supplied evidence does not report quantitative kinetic values, activation wavelengths, construct architecture, or biochemical characterization. Validation is described for mammalian-cell applications, but broader organismal scope, recombination-specific demonstrations, and independent replication are not established from the provided material.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Observations

successMammalian Cell Lineapplication demo

Inferred from claim claim_1 during normalization. BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light. Derived from claim claim_1. Quoted text: Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_2 during normalization. BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2. Derived from claim claim_2. Quoted text: This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.

Source:

clustering kinetics comparison(substantially faster)de-clustering kinetics comparison(substantially faster)
successMammalian Cell Lineapplication demo

Inferred from claim claim_5 during normalization. At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light. Derived from claim claim_5. Quoted text: At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_6 during normalization. BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells. Derived from claim claim_6. Quoted text: BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_1 during normalization. BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light. Derived from claim claim_1. Quoted text: Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_2 during normalization. BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2. Derived from claim claim_2. Quoted text: This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.

Source:

clustering kinetics comparison(substantially faster)de-clustering kinetics comparison(substantially faster)
successMammalian Cell Lineapplication demo

Inferred from claim claim_5 during normalization. At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light. Derived from claim claim_5. Quoted text: At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_6 during normalization. BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells. Derived from claim claim_6. Quoted text: BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_1 during normalization. BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light. Derived from claim claim_1. Quoted text: Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_2 during normalization. BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2. Derived from claim claim_2. Quoted text: This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.

Source:

clustering kinetics comparison(substantially faster)de-clustering kinetics comparison(substantially faster)
successMammalian Cell Lineapplication demo

Inferred from claim claim_5 during normalization. At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light. Derived from claim claim_5. Quoted text: At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_6 during normalization. BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells. Derived from claim claim_6. Quoted text: BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_1 during normalization. BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light. Derived from claim claim_1. Quoted text: Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_2 during normalization. BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2. Derived from claim claim_2. Quoted text: This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.

Source:

clustering kinetics comparison(substantially faster)de-clustering kinetics comparison(substantially faster)
successMammalian Cell Lineapplication demo

Inferred from claim claim_5 during normalization. At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light. Derived from claim claim_5. Quoted text: At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_6 during normalization. BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells. Derived from claim claim_6. Quoted text: BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_6 during normalization. BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells. Derived from claim claim_6. Quoted text: BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_1 during normalization. BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light. Derived from claim claim_1. Quoted text: Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_2 during normalization. BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2. Derived from claim claim_2. Quoted text: This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.

Source:

clustering kinetics comparison(substantially faster)de-clustering kinetics comparison(substantially faster)
successMammalian Cell Lineapplication demo

Inferred from claim claim_5 during normalization. At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light. Derived from claim claim_5. Quoted text: At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_1 during normalization. BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light. Derived from claim claim_1. Quoted text: Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_2 during normalization. BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2. Derived from claim claim_2. Quoted text: This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.

Source:

clustering kinetics comparison(substantially faster)de-clustering kinetics comparison(substantially faster)
successMammalian Cell Lineapplication demo

Inferred from claim claim_5 during normalization. At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light. Derived from claim claim_5. Quoted text: At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_6 during normalization. BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells. Derived from claim claim_6. Quoted text: BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_1 during normalization. BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light. Derived from claim claim_1. Quoted text: Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_2 during normalization. BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2. Derived from claim claim_2. Quoted text: This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.

Source:

clustering kinetics comparison(substantially faster)de-clustering kinetics comparison(substantially faster)
successMammalian Cell Lineapplication demo

Inferred from claim claim_5 during normalization. At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light. Derived from claim claim_5. Quoted text: At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_6 during normalization. BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells. Derived from claim claim_6. Quoted text: BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_1 during normalization. BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light. Derived from claim claim_1. Quoted text: Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_2 during normalization. BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2. Derived from claim claim_2. Quoted text: This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.

Source:

clustering kinetics comparison(substantially faster)de-clustering kinetics comparison(substantially faster)
successMammalian Cell Lineapplication demo

Inferred from claim claim_5 during normalization. At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light. Derived from claim claim_5. Quoted text: At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.

Source:

successMammalian Cell Lineapplication demo

Inferred from claim claim_6 during normalization. BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells. Derived from claim claim_6. Quoted text: BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.

Source:

Supporting Sources

Ranked Claims

Claim 1application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 2application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 3application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 4application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 5application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 6application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 7application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 8application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 9application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 10application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 11application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 12application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 13application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 14application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 15application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 16application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 17application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 18application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 19application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 20application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 21application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 22application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 23application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 24application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 25application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 26application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 27application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 28application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 29application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 30application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 31application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 32application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 33application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 34application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 35application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 36application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 37application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 38application scopesupports2024Source 1needs review

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 39comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 40comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 41comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 42comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 43comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 44comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 45comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 46comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 47comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 48comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 49comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 50comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 51comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 52comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 53comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 54comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 55comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 56comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 57comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 58comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 59comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 60comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 61comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 62comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 63comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 64comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 65comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 66comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 67comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 68comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 69comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 70comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 71comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 72comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 73comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 74comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 75comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 76comparative performancesupports2024Source 1needs review

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.
clustering kinetics comparison substantially fasterde-clustering kinetics comparison substantially faster
Claim 77engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 78engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 79engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 80engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 81engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 82engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 83engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 84engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 85engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 86engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 87engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 88engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 89engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 90engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 91engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 92engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 93engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 94engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 95engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 96engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 97engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 98engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 99engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 100engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 101engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 102engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 103engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 104engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 105engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 106engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 107engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 108engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 109engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 110engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 111engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 112engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 113engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 114engineered capabilitysupports2024Source 1needs review

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.
Claim 115environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 116environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 117environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 118environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 119environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 120environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 121environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 122environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 123environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 124environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 125environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 126environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 127environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 128environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 129environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 130environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 131environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 132environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 133environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 134environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 135environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 136environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 137environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 138environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 139environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 140environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 141environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 142environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 143environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 144environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 145environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 146environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 147environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 148environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 149environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 150environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 151environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 152environmental sensitivitysupports2024Source 1needs review

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.
Claim 153modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 154modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 155modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 156modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 157modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 158modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 159modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 160modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 161modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 162modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 163modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 164modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 165modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 166modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 167modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 168modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 169modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 170modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 171modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 172modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 173modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 174modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 175modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 176modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 177modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 178modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 179modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 180modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 181modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 182modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 183modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 184modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 185modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 186modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 187modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 188modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 189modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 190modulation strategysupports2024Source 1needs review

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.
Claim 191multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 192multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 193multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 194multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 195multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 196multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 197multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 198multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 199multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 200multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 201multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 202multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 203multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 204multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 205multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 206multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 207multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 208multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 209multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 210multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 211multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 212multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 213multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 214multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 215multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 216multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 217multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 218multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 219multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 220multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 221multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 222multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 223multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 224multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 225multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 226multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 227multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 228multiplexing capabilitysupports2024Source 1needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 229use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 230use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 231use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 232use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 233use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 234use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 235use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 236use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 237use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 238use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 239use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 240use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 241use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 242use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 243use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 244use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 245use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 246use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 247use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 248use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 249use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 250use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 251use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 252use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 253use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 254use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 255use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 256use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 257use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 258use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 259use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 260use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 261use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 262use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 263use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 264use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 265use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 266use constraintsupports2024Source 1needs review

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.
recommended culture temperature upper range 30 °C
Claim 267application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 268application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 269application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 270application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 271application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 272application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 273application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 274application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 275application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 276application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 277application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 278application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 279application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 280application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 281application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 282application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 283application constraintsupports2023Source 2needs review

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C
temperature suitability threshold below ∼30 °C
Claim 284application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 285application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 286application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 287application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 288application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 289application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 290application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 291application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 292application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 293application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 294application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 295application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 296application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 297application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 298application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 299application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 300application scopesupports2023Source 2needs review

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.
Claim 301comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 302comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 303comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 304comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 305comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 306comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 307comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 308comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 309comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 310comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 311comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 312comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 313comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 314comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 315comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 316comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 317comparative performancesupports2023Source 2needs review

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2
Claim 318engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 319engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 320engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 321engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 322engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 323engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 324engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 325engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 326engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 327engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 328engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 329engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 330engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 331engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 332engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 333engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 334engineering resultsupports2023Source 2needs review

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light
Claim 335modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 336modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 337modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 338modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 339modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 340modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 341modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 342modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 343modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 344modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 345modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 346modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 347modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 348modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 349modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 350modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 351modulation strategysupports2023Source 2needs review

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.
Claim 352multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 353multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 354multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 355multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 356multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 357multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 358multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 359multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 360multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 361multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 362multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 363multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 364multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 365multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 366multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 367multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 368multiplexing capabilitysupports2023Source 2needs review

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.
Claim 369temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.
Claim 370temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.
Claim 371temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.
Claim 372temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.
Claim 373temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.
Claim 374temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.
Claim 375temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.
Claim 376temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.
Claim 377temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.
Claim 378temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.
Claim 379temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.
Claim 380temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.
Claim 381temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.
Claim 382temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.
Claim 383temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.
Claim 384temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.
Claim 385temperature responsesupports2023Source 2needs review

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.

Approval Evidence

2 sources14 linked approval claimsfirst-pass slug bclovclust
This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.

Source:

This variant, BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2.

Source:

application scopesupports

BcLOVclust can be applied to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.

Source:

comparative performancesupports

BcLOVclust shows substantially faster clustering and de-clustering kinetics than Cry2.

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.

Source:

engineered capabilitysupports

BcLOVclust is an engineered BcLOV4-derived variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

Source:

environmental sensitivitysupports

BcLOVclust is temperature sensitive, and its light-induced clusters dissolve faster at higher temperature despite constant illumination.

Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination.

Source:

modulation strategysupports

BcLOVclust clustering magnitude can be strengthened by appending a FUS intrinsically disordered region or by selecting the fused fluorescent protein.

The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused.

Source:

multiplexing capabilitysupports

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to control independent protein condensates with light.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.

Source:

use constraintsupports

BcLOVclust is currently best suited for cells and organisms cultured below approximately 30 °C rather than physiological mammalian temperatures.

While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.

Source:

application constraintsupports

Current use of BcLOVclust is suited for organisms that can be cultured below approximately 30 degrees Celsius.

While its usage is currently suited for organisms that can be cultured below ∼30 °C

Source:

application scopesupports

BcLOVclust can be used to control signaling proteins and stress granules in mammalian cells.

BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells.

Source:

comparative performancesupports

BcLOVclust has dramatically faster clustering and de-clustering kinetics than Cry2.

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2

Source:

engineering resultsupports

A BcLOV4 variant was engineered that clusters in the cytoplasm and does not associate with the membrane in response to blue light.

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light

Source:

modulation strategysupports

BcLOVclust clustering magnitude can be increased by appending a FUS intrinsically disordered region or by optimizing the fused fluorescent protein.

The magnitude of BcLOVclust clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by optimizing the fluorescent protein to which it was fused.

Source:

multiplexing capabilitysupports

At low temperatures, BcLOVclust and Cry2 can be multiplexed in the same cells to independently control protein condensates.

At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates.

Source:

temperature responsesupports

BcLOVclust retains temperature sensitivity such that light-induced clustering is transient and spontaneous declustering increases with temperature.

BcLOVclust retained the temperature sensitivity of BcLOV4 such that light induced clustering was transient, and the rate of spontaneous declustering increased with temperature.

Source:

Comparisons

Source-backed strengths

The available evidence states that BcLOVclust clustered over many cycles and showed dramatically faster clustering and de-clustering kinetics than Cry2. It has also been reported as applicable for controlling signaling proteins and stress granules in mammalian cells.

Source:

This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2.

Source:

BcLOVclust, clustered over many cycles with dramatically faster clustering and de-clustering kinetics compared to Cry2

Source:

allowing us to engineer a variant of BcLOV4 that clusters in the cytoplasm and does not associate with the membrane in response to blue light

Compared with BcLOV4 photoreceptor

BcLOVclust and BcLOV4 photoreceptor address a similar problem space because they share recombination, signaling.

Shared frame: same top-level item type; shared target processes: recombination, signaling; same primary input modality: light

Compared with DspA

BcLOVclust and DspA address a similar problem space because they share recombination, signaling.

Shared frame: same top-level item type; shared target processes: recombination, signaling; same primary input modality: light

Compared with melanopsin

BcLOVclust and melanopsin address a similar problem space because they share recombination, signaling.

Shared frame: same top-level item type; shared target processes: recombination, signaling; same primary input modality: light

Relative tradeoffs: appears more independently replicated; looks easier to implement in practice.

Ranked Citations

  1. 1.

    Seeded from load plan for claim claim_2. Extracted from this source document.

  2. 2.

    Extracted from this source document.